Use and outcomes of epoetin alfa and darbepoetin alfa for anemic cancer patients in outpatient community practice settings.

被引：1
|
作者：
Fahrbach, KR
Frame, D
Sercus, B
Schenkel, B
机构：
[1] Metaworks Inc, Res & Stat, Medford, MA USA
[2] Johnson & Johnson Pharmaceut Serv LLC, Hlth Econ & Pricing, Raritan, NJ USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.5588.5588
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5588
引用
收藏
页码：485B / 486B
页数：2
相关论文
共 50 条
  • [21] A multicenter retrospective cohort study of practice patterns and clinical outcomes of the use of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia
    Schwartzberg, L
    Shiffman, R
    Tomita, D
    Stolshek, B
    Rossi, G
    Adamson, R
    CLINICAL THERAPEUTICS, 2003, 25 (11) : 2781 - 2796
  • [22] Comparable results seen with darbepoetin and epoetin alfa in breast cancer patients
    不详
    ONCOLOGY-NEW YORK, 2005, 19 (03): : 368 - +
  • [23] Comment: Epoetin alfa versus darbepoetin alfa for cancer patients with treatment-related anemia - Reply
    Cersosimo, RJ
    Jacobson, DR
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (05) : 999 - 999
  • [24] Effectiveness of darbepoetin alfa versus epoetin alfa in patients with chemotherapy-induced anemia treated in clinical practice
    Patton, J
    Reeves, T
    Wallace, J
    ONCOLOGIST, 2004, 9 (04): : 451 - 458
  • [25] Dosing patterns, drug costs, and hematologic outcome in anemic patients with chronic kidney disease switching from darbepoetin alfa to epoetin alfa
    Hymes, Jeffrey
    Bickimer, Tammy
    Jackson, James H.
    Bookhart, Brahim K.
    Mody, Samir H.
    Piech, Catherine Tak
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (08) : 1931 - 1937
  • [26] Utilization of epoetin alfa (EPO) and darbepoetin alfa (DARB) in critically ill patients.
    Mody, S.
    Watson, S.
    McKenzie, R. S.
    Raut, M.
    CRITICAL CARE MEDICINE, 2006, 34 (12) : A131 - A131
  • [27] Epoetin alfa and darbepoetin alfa: effects on ventricular hypertrophy in patients with chronic kidney disease
    Chen, Han-Hsiang
    Tarng, Der-Cherng
    Lee, Kun-Feng
    Wu, Chih-Jen
    Chen, Yi-Chou
    JOURNAL OF NEPHROLOGY, 2008, 21 (04) : 543 - 549
  • [28] An audit comparing subcutaneous epoetin alfa to intravenous darbepoetin alfa in chronic hemodialysis patients
    Summers, S
    Winnett, G
    Matijevic, A
    Carmichael, D
    Almond, M
    DIALYSIS & TRANSPLANTATION, 2005, 34 (06) : 358 - +
  • [29] Haemoglobin fluctuations in haemodialysis patients receiving intravenous epoetin alfa or intravenous darbepoetin alfa
    Walker, R.
    Pussell, B. A.
    VALUE IN HEALTH, 2007, 10 (03) : A103 - A103
  • [30] Resistance index to epoetin alfa and to darbepoetin alfa in chronic hemodialysis patients:: A cohort study
    Perez-Garcia, R.
    Benitez, P. Rodriguez
    Jofre, R.
    Lopez-Gomez, J. M.
    Villaverde, M. T.
    Blanco, A.
    Blanco, S.
    Sanchez, M.
    NEFROLOGIA, 2007, 27 (03): : 340 - 349
12345